Marshall Wace, LLP 180 Life Sciences Corp. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.81 - $2.53 $127,169 - $397,207
-156,999 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.53 - $3.9 $361,420 - $557,130
-142,854 Reduced 47.64%
156,999 $407,000
Q4 2021

Feb 14, 2022
BUY
$3.27 - $6.38 $980,519 - $1.91 Million
299,853 New
299,853 $1.17 Million

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $81.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email